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Abstract
Airborne pathogens are associated with the spread of infectious diseases and increased morbidity 
and mortality. Herein we present an emerging chemical free, nanotechnology-based method for 
airborne pathogen inactivation. This technique is based on transforming atmospheric water vapor 
into Engineered Water Nano-Structures (EWNS) via electrospray. The generated EWNS possess a 
unique set of physical, chemical, morphological and biological properties. Their average size is 25 
nm and they contain reactive oxygen species (ROS) such as hydroxyl and superoxide radicals. In 
addition, EWNS are highly electrically charged (10 electrons per particle on average). A link 
between their electric charge and the reduction of their evaporation rate was illustrated resulting in 
an extended lifetime (over an hour) at room conditions. Furthermore, it was clearly demonstrated 
that the EWNS have the ability to interact with and inactivate airborne bacteria. Finally, inhaled 
EWNS were found to have minimal toxicological effects, as illustrated in an acute in-vivo 
inhalation study using a mouse model. In conclusion, this novel, chemical free, nanotechnology-
based method has the potential to be used in the battle against airborne infectious diseases.
Introduction
Airborne pathogens are associated with the spread of numerous infectious diseases1,2 and 
significant mortality and morbidity.3 Typical examples of airborne infectious diseases 
include tuberculosis (Mycobacterium tuberculosis), and viral diseases such as avian 
influenza AI/H5N14–6 and severe acute respiratory syndrome (SARS).7 Concerns about the 
evolution and spread of antibiotic resistant bacteria, such as multidrug resistant 
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tuberculosis,8,9 reveal the limitations of antibiotics, while the SARS outbreak and the AI/
H5N1 pandemic influenza exemplify the difficulties associated with vaccine development.10
The need to disinfect ambient air was recognized as early as the 1930s11 and remains one of 
the main strategies used in controlling the transmission of airborne diseases.12 The use of air 
disinfection as a disease control strategy is regaining considerable interest lately, particularly 
in high-risk microenvironments with a high density of people, such as hospitals, classrooms 
and mass transportation vehicles (e.g., buses, aircraft cabin, trains).13,14
Current air disinfection technologies, such as the use of upper-room UV-C irradiation 
(Ultraviolet 254 nm),15,16 high efficiency particulate (HEPA) air filtration17 and 
photocatalysis,18 have shortcomings. UV is associated with health risks,19,20 requires the 
upper room installation of UV fixtures, and relies on a well-mixed air concept. HEPA filters 
remove bacteria and viruses from the air effectively, but there are excessive costs associated 
with the energy needed to circulate air through the filter, and for filter replacement.21 
Recently, nanoparticle photocatalysis22 using UV-A has been used to disinfect surfaces.23 
However, nanoparticle photocatalysis is limited to surfaces and the commonly used 
nanomaterials, such as Ag or TiO2, cannot be used for airborne pathogen inactivation due to 
their possible toxicological effects when inhaled.24–26
Furthermore, the use of other disinfection methods which are based on the use of biocidal 
gases such ethylene oxide,27 hydrogen peroxide,28 ozone29 and chlorine dioxide30 also have 
limitations associated with toxicity,31 potential material damage, and in some instances 
downtime of the space or equipment being treated. Personal protective equipment (e.g., 
surgical masks and N-95 type respirators), although commonly used to prevent infectious 
disease transmission, are not always effective or practical in the battle against airborne 
infectious diseases.32
Herein, we describe a novel, nanotechnology-based, air disinfection technique using 
Engineered Water Nano-Structures (EWNS) generated via electrospray. These nanoscale 
particles possess unique physicochemical and biological properties. They are highly mobile 
due to their nanoscale size, remain suspended in the air for hours, contain reactive oxygen 
species, and interact with and inactivate airborne bacteria. More importantly, this is a 
chemical-free and toxicologically benign method, which can be used to decrease the risk of 
airborne infectious diseases in a wide variety of environmental settings.
Materials and methods
EWNS synthesis
EWNS were synthesized by electrospraying condensed atmospheric water vapor recovered 
from room air. Electrospraying is used widely to aerosolize liquids and to synthesize 
polymeric and ceramic particles,33 as well as fibers34 of controlled size. It is based on 
applying a strong electric field to a fine capillary containing a liquid.35 The accumulated 
charges at the liquid–air interface, in combination with a high electric field, result in a strong 
electric force that creates a streaming jet (Taylor cone)36 that eventually breaks into 
droplets. The droplet size depends on the initial electrospray parameters (liquid conductivity, 
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liquid flow rate and electric field).37 The fine droplets are highly unstable due to their high 
electric surface charge,38 and continue to break into smaller droplets described by the 
Rayleigh theory:39
(1)
where q [C] is the total charge of the droplet, ε0 [F m−1] the permittivity of the vacuum and 
γ [N m−1] the surface tension of water.
Fig. 1a illustrates the electrospray module used for the synthesis of EWNS described by Seto 
et al.40 The source of the liquid is water vapor from the surrounding air, condensed on a 
Peltier-cooled electrode, maintained at 6 °C. This eliminates the need for a continuous 
supply of water and minimizes the presence of organic contaminants. A high voltage (5 kV) 
is then applied between the electrode and a grounded counter electrode placed 5 mm from 
the electrode. The strong electric field (107 V m−1) between the two electrodes causes 
negative charges to accumulate on the surface of the condensed water, leading to the 
formation of the Taylor cone.41 It is worth mentioning that the module consumes 
approximately 6 W of power and operates at 12 V. As a result, highly charged water 
droplets form and continue to break into smaller particles as described by Rayleigh theory 
(Fig. 1b). During the formation of the water droplets the high electric field causes some 
water molecules to split and can strip off electrons, resulting in a high number of reactive 
oxygen species (ROS).42 The concurrently generated, short lived ROS (with a lifespan in the 
order of nanoseconds)43 are encapsulated in the EWNS (Fig. 1c). As demonstrated below 
due to their size and high electric charge the EWNS are highly mobile and remain airborne 
for a long time, potentially colliding with pathogens suspended in air, and resulting in 
microbial inactivation (Fig. 1d).
EWNS physicochemical characterization
Surface electric charge measurements of EWNS—An electrospray module was 
placed in a 45 L chamber with temperature and relative humidity maintained at 21 °C and 
50% respectively (Fig. S1a‡). The particle number concentration was measured using a 
scanning mobility particle sizer (SMPS, model 3936, TSI, Shoreview, MN) and the current 
was measured concurrently with a Faraday aerosol electrometer (TSI, model 3068B, 
Shoreview, MN). The SMPS and the aerosol electrometer were both sampling at 0.5 L 
min−1 flow rate. The particle number concentration and the aerosol current were measured 
for 120 s. The process was repeated ten times.
Size and lifetime measurements of EWNS—The Atomic Force Microscope (AFM), 
Asylum MFP-3D (Asylum Research, Santa Barbara, CA) and the AC240T probes 
(Olympus, Tokyo, Japan) were used to measure the size and lifetime of EWNS. The AFM 
scan rate was 1 Hz and the scanned area 5 µm × 5 µm with 256 scan lines. All images were 
‡Electronic supplementary information (ESI) available: Control experiments procedures and data, membrane permeability study, 
experimental setups, and AFM size measurement diagrams. See DOI: 10.1039/c3en00007a
Pyrgiotakis et al. Page 3













subjected to 1st order image flattening with the Asylum software (range of 100 nm and 
threshold of 100 pm for the mask).
An electrospray module was used to spray the EWNS on a freshly cleaved mica surface 
(Ted Pella, Redding, CA). The spraying time and distance was optimized to 60 s and 2 cm 
respectively, to avoid particle coalescence and the formation of irregular shaped droplets on 
the mica surface. The surface was imaged immediately after spraying using AFM. The 
contact angle of a freshly cleaved, unmodified, mica surface is close to 0°44 so the EWNS 
were spread on the mica surface adopting a dome like shape (Fig. S2‡). The diameter and 
the height of the spread droplet were measured directly from the AFM topography and used 
to calculate the volume of the dome-like spread EWNS. Assuming that airborne EWNS 
have the same volume, an equivalent diameter can be calculated as follows:
(2)
where h is the measured height and a is the measured radius of the spread droplet (Fig. S2‡). 
In total, 40 droplets were measured using AFM and the EWNS size distribution was 
constructed. The room air temperature and relative humidity (RH) were maintained constant 
during the experiments at 21 °C and 45% respectively.
To estimate the EWNS lifetime, an AFM image of the EWNS sprayed on the mica substrate 
(top to bottom scanning) was acquired, immediately after spraying, and every 10 minutes 
thereafter for one hour. The images were analyzed to determine any topographic changes 
(size) associated with the EWNS. A clean mica surface kept in the same room conditions 
was scanned immediately after cleaving and at the end of the experiments (60 minutes later) 
in order to assess and control for cross contamination from ambient air particles.
Lifetime measurements of airborne EWNS—In order to investigate the lifetime of the 
airborne EWNS additional experiments were performed. The bacteria inactivation chamber 
was filled with EWNS aerosol until the particle number concentration level reached 15 000 
particles cm−3. The chamber walls were lined with aluminum sheets that were grounded to 
minimize electrostatic particle losses. Two mixing fans were used to ensure homogeneity in 
the chamber. At that point the EWNS production stopped and the number concentration of 
the EWNS was monitored with an SMPS (model 3936, TSI, Shoreview, MN) as a function 
of time up to for 4 hours.
ROS characterization of EWNS—Electron Spin Resonance (ESR) spin trapping was 
used to detect the presence of shortlived free radical intermediates in the EWNS. Radicals 
were measured using the addition-type reaction of a short-lived radical with a compound 
(spin trap) to form a relatively long-lived paramagnetic free radical product (spin adduct), 
which can then be studied using conventional ESR.
A 45 L chamber with controlled humidity and temperature (T = 21 °C, RH = 50%), 
containing 4 EWNS electrospray modules was used to generate the EWNS aerosol (Fig. 
S1b‡). The aerosol was sampled directly beneath the modules. The aerosol was bubbled 
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through a 650 µm midget bubbler (Ace Glass, Vineland, NJ) containing a solution of 235 
mM DEPMPO (5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide), (Oxis International 
Inc. Portland, OR) at a concentration of 11 000 # cc−1 and a time period for 15 minutes. 
DEPMPO was used instead of the more commonly used 5,5-dimethyl-1-pyrroline-N-oxide 
(DMPO) because of the increased stability it offers for spin adducts. All ESR measurements 
were conducted using a Bruker EMX spectrometer (Bruker Instruments Inc. Billerica, MA, 
USA) and a flat cell assembly. Hyperfine couplings were measured (to 0.1 G) directly from 
magnetic field separation using potassium tetraperoxochromate (K3CrO8) and 1,1-
diphenyl-2-picrylhydrazyl (DPPH) as reference standards. The Acquisit program (Bruker 
Instruments Inc. Billerica, MA, USA) was used for data acquisitions and analyses.
Airborne bacteria inactivation experiments
Bioaerosol—Serratia marcescens was selected as a test bioaerosol since it is a standard 
test organism for this type of experiment. Furthermore its airborne viability and behavior is 
well documented45 and widely accepted as a test aerosol16 and used to evaluate the efficacy 
of various techniques to inactivate airborne bacteria such as UV.16,46 Furthermore, the 
authors have significant experience in aerosolizing this microorganism and creating stable 
conditions in room air conditions.16,47–49 It is also worth noting though that despite the fact 
that Serratia marcescens is not a common human pathogen, there are cases where it has 
been identified as the cause of serious infections including wound infections.50
Development of an EWNS aerosol generator—For the airborne bacteria inactivation 
experiments, a high volume and concentration EWNS aerosol generator was constructed. 
The generator can provide up to 15 L min−1 of EWNS aerosol with a particle number 
concentration up to 500 000 # cm−3 (Fig. S3‡). Organic-free, de-ionized water (18.1 MΩ 
cm, purified with Barnstead Nanopure, Thermo Scientific, Rockford, IL) was used in the 
synthesis of the EWNS (Fig. S3‡). The generated ozone was removed by passing the aerosol 
through three freshly coated, glass honeycomb denuders previously developed by the 
authors.51 The denuders were coated with a solution of 140 mL of DI (de-ionized) water, 5 g 
of NaNO3, 5 g of CaCO3 and 5 g of glycerol. After the coating, the denuders were placed on 
paper towels to remove excess solution and are then left to dry for 24 hours under 
refrigeration. For each experiment fresh denuders were used.
Bioaerosol generation system—A CN-6 Collison nebulizer (BGI Inc., Waltham, MA) 
operated with HEPA-filtered dry air at 103 kPa (15 psi) was used to aerosolize a S. 
marcescens solution. The concentration of the stock solution was optimized at 104.5 # mL−1 
to produce in airborne bacteria concentrations of 5–7 cfu L−1 (Colony Forming Units per L) 
representing relevant airborne bacteria concentrations.16 In order to avoid large PBS 
droplets with suspended bacteria the nebulizer output was mixed with an equal flow of dry 
air in a 20 L drum.
Airborne bacteria inactivation experiments protocol—The EWNS generator and a 
S. marcescens bioaerosol generation system were connected to a 1 m3 polyacrylic 
environmental chamber that was lined with grounded, aluminum panels to minimize particle 
losses (Fig. S4‡). The two aerosol streams were mixed in the environmental chamber and 
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the number of culturable airborne bacteria was monitored as a function of time. The mixing 
was assisted with two mixing fans. Input and output airflows in the chamber were fully 
controlled to simulate different air change scenarios. Two air changes per hour (ACH) 
scenarios were evaluated, 1.7 and 2.9. During all experiments the temperature and relative 
humidity in the chamber were monitored and maintained at 21–23 °C and 45–55%, 
respectively.
In summary the protocol for the experiments is as follows: The two aerosols started at t = 0 
min. The aerosol flows were maintained constant until steady state conditions were reached 
in the chamber. This corresponds to an approximate time of three air changes in the chamber 
(60 for the 2.9 ACH and 105 minutes for the 1.7 ACH scenario). An air sample was 
obtained using the biosampler at three time intervals during the time required to reach steady 
state (including steady state). After completing the steady state portion of the inactivation 
experiment, all the input and output flows stopped and the bacteria concentration in the air 
was measured for one hour by sampling every 20 minutes (decay experiment). Experiments 
were performed in triplicate.
All air samples were collected using the N6 single stage viable impactor (BGI Inc. Waltham, 
MA), loaded with tryptic soy agar (TSA) plates, at 28.3 lpm with the #6 stage (650 nm cut 
point). Prior to collection of each air sample, a dummy plate was used for 30 s to void the 
dead space of the sampling line. The air sampling time was optimized at 1 minute. The 
culture plates were grown for 48 h prior to colony counting. Positive hole corrections were 
applied to all plate counts.52 Pre and post aerosolization samples were taken directly from 
the Collison jar to ensure that the S. marcescens stock solution was viable throughout the 
experiments.
Control experiments—As a control experiment, instead of the EWNS aerosol, HEPA 
filtered air at the same airflow was supplied in the chamber while all other procedures, 
sampling and culturing protocols were kept the same. In addition, ozone control experiments 
were performed in order to assess any effect of ozone on bacteria inactivation. Furthermore, 
control experiments were conducted to verify that the inactivation occurs in air and not on 
the TSA plates of the biosampler post collection. All control experiment protocols are 
described in detail in the ESI.‡
Bioaerosol size distribution experiments—It is also worth mentioning that in 
separate experiments, bioaerosol size distribution measurements of the culturable bacteria 
were performed in triplicate for each ACH scenario. In more detail, the S. marcescens 
aerosol size distribution was measured using the six stage viable sampler (BGI Inc., 
Waltham, MA), loaded with TSA plates and operated at 28.3 lpm flow rate. In a separate 
experiment, with identical HEPA filtered input/output chamber flows and chamber input 
EWNS concentration levels, a condensation particle counter (CPC) was used to measure in 
real time the corresponding particle number concentration in the chamber at steady state. 
The EWNS size distribution was then estimated based on the CPC number concentration 
and the AFM size distribution measurements. A negative pressure of 0.2–0.3 in H2O 
(49.768–74.652 Pa) was always maintained in the chamber in order to comply with 
biosafety requirements.
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Bacterial membrane permeability experiments
Bacterial membrane permeability was evaluated both qualitatively and quantitatively using 
Transmission Electron Microscopy (TEM) and the membrane permeability assay 
respectively. The extent of nuclear staining, within a population of bacteria, by membrane-
impermeant and permeant fluorescent nucleic acid dyes is a useful quantifiable indicator of 
membrane damage.53–55 The details of the assay preparation and TEM imaging are included 
in the ESI.‡
Acute inhalation toxicological evaluation of EWNS using BALB/c mouse model
The toxicological profile of inhaled EWNS was assessed using a BALB/c mouse model. 
This particular model is considered a sensitive model for assessing acute lung injury and 
inflammation effects related to inhalation. In more detail:
Animal welfare protocol—The Harvard Medical Area's Animal Use Committee 
approved animal protocols were used in this study. Forty-four male BALB/c mice (22–28 g) 
were obtained from Taconic Farms (Taconic Farms, Hudson, NY). Mice were allowed to 
acclimate to the animal facility for 4–5 days prior to start of experiments.
Exposure system—Fig. S5‡ shows the EWNS generation and exposure system used in 
the study. The EWNS generator previously described was connected to a BuxCo system that 
has the ability to monitor the breathing pattern of the animals during the aerosol exposure.56 
The BuxCo system consisted of 8 individual cages (PLY42211 V1.0, BuxCo systems, 
Wilmington, NC) with attached transducers (TRD5700, BuxCo systems, Wilmington, NC) 
that were connected to the Max II acquisition center (BuxCo systems, Wilmington, NC) 
operated by the BioSystem XA data acquisition and analysis software (BuxCo systems, 
Wilmington, NC).
The animals were divided into 7 groups of 6 mice each. In each group, four mice were 
exposed to EWNS aerosol and two mice were exposed to the same atmosphere without the 
EWNS (EWNS were removed with an in-line HEPA filter, control group). Three EWNS 
exposure levels were tested at 10 000, 40 000 and 60 000 # cm−3. It is worth noting that the 
doses selected for the toxicological characterization were higher than the EWNS dose used 
in the bacteria inactivation experiments. To estimate the deposited aerosol in the respiratory 
tract, the Multiple Path Particle Dosimetry model was used (MPPD2).57 During the 
exposure, important breathing parameters (tidal volume and breathing frequency) related to 
inhalation toxicity were monitored and recorded.26,58,59
Bronchoalveolar and nasal lavage protocol—At 24 hours post-inhalation exposure 
to EWNS, mice were humanely killed with isoflurane anesthesia followed by 
exsanguination. The trachea was exposed and cannulated, and bronchoalveolar lavages 
(BAL) of the lungs were repeated 12 times with 0.75 ml of Ca2+ and Mg2+ free PBS. Nasal 
lavage (NL) was also done with a single wash of 1.5 ml of the same PBS solution. Lavaged 
cells were separated from the supernatant in all washes by centrifugation. Total and 
differential cell counts and hemoglobin measurements were made from the cell pellets. The 
combined acellular supernatant fractions from the first two washes was analyzed for 
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indicators of injury and inflammation including albumin, hemoglobin, lactate dehydrogenase 
(LDH),60 myeloperoxidase (MPO)61 as well as inflammatory cells,62 such as macrophages 
and neutrophils.63 The analysis was performed according to a standardized bioassay 
system.64
Statistics—All BAL and NL parameters were analyzed using analysis of variance 




The EWNS possess a set of physicochemical properties that are unique and play an 
important role in the airborne bacteria inactivation. In more detail:
Surface charge—The surface charge was estimated by concurrently measuring the 
aerosol current and the number concentration of the EWNS aerosol. The experimental 
results showed that each EWNS has an average charge of approximately 10 ± 2 electron. 
The value is in agreement with previously published literature by Seto et al. that described 
the development of the module.40 Although characterization of the precise charge 
distribution within the droplet is beyond the scope of the study, it is reasonable to assume 
that the negative charges would tend to accumulate on the outer surface of the water 
droplets, as has been previously shown for the case of charged water droplets,65–68 as 
illustrated in Fig. 1c.
It is also worth noting that the surface charge is an important determinant of surface tension 
and evaporation rate. Nielsen et al.69 have recently shown size–charge association for the 
case of a charged, micron-size pure water droplet. It was demonstrated that the surface 
charge effectively increases surface tension leading to a reduced evaporation rate. The 
unusually high surface charge associated with EWNS may explain their size stability over 
time and the slow evaporation rate of EWNS (see section below on lifetime).
Size and lifetime—The size of the EWNS is also a very important property that 
determines their fate and transport in the environment. Due to the aforementioned particle 
size– charge association, traditional airborne particle size measurement instruments that 
utilize charge neutralizers (i.e. scanning mobility particle sizer with Krypton 85 or X-ray 
neutralizers) cannot be used in order to accurately measure size distribution of the EWNS. 
The SMPS is used here strictly to measure particle number concentration.
In this study, an AFM was employed to image the EWNS on a mica surface and extrapolate 
the airborne size distribution of EWNS. Fig. 2 represents the AFM results on the size 
distribution and lifetime measurements of EWNS. Fig. 2a shows the AFM obtained 
topography of the EWNS sprayed on a mica surface. Fig. 2b illustrates the size distribution 
of the EWNS based on the equivalent dome volume. In addition Fig. 2c – h show 6 
consecutive scans, every 10 minutes, of EWNS sprayed on a mica surface. Fig. 2i and j 
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show the control mica, which was not sprayed with EWNS but stayed in the same room and 
conditions until the end of the experiments.
As shown in Fig. 2b the EWNS appear to be polydisperse in size and follow a log normal 
distribution with mean diameters of 25 nm, mode of 23 nm and a standard deviation of 9 nm 
(geometric standard deviation 1.41). Moreover, the observed polydispersity can be explained 
from the variation of the surface charge,40 the randomness of the Rayleigh effect and the 
inevitable over-time evaporation.
Furthermore, as illustrated in Fig. 2c–h, the EWNS size remained approximately the same 
for the entire one-hour duration of the AFM experiment indicating very low evaporation in 
room conditions. This is in agreement with the previous study by Nielsen et al.,69 which 
illustrated that highly charged water droplets, have a very low evaporation rate.70 It is also 
evident from Fig. 2i and j that there are no particles present on the control mica samples that 
can be attributed either to mica residue or to any ambient particle deposition.
Lifetime measurements of airborne EWNS—Fig. 3 shows the number concentration 
of the airborne EWNS in a closed 1 m3 chamber as a function of time after the EWNS 
production has stopped.
As shown, 50% of the EWNS still remain in the chamber after one hour and EWNS 
continue to be present in the chamber even after 4 h. As expected the population is 
decreased over time as a result of the inevitable particle losses due to collisions with the 
walls, potential coagulation, etc. It is obvious from these data that the EWNS remain 
airborne for hours, as indicated in the previously discussed AFM experiments.
ROS characterization—The results of ESR, after subtraction of control (background) 
ozone (in order to take into consideration only intrinsic ROS) of EWNS are presented in Fig. 
4. The ESR spectrum clearly indicates the presence of two ROS species, with OH• being the 
predominant species, and O2−present in smaller amounts. These results are in agreement 
with the literature on electrospraying.42,71
Airborne bacteria inactivation experiments
Fig. 5 presents the airborne bacteria inactivation results. More specifically Fig. 5a and b 
show the estimated EWNS aerosol size distribution and the culturable bacteria size 
distribution (measured by the N6 6-stage viable impactor), in the environmental chamber at 
steady state conditions for the 2.9 and 1.7 ACH scenarios, respectively. It should be 
mentioned here that since size is not an accurate method of measuring the EWNS 
distribution, it was estimated based on AFM results and the total number that was measured 
with a CPC. The airborne bacteria aerodynamic diameter in both ACH scenarios was found 
to be 2.05 µm which is in agreement with the literature.16 Furthermore, the average 
concentration of S. marcescens was found to be 5 and 7 cfu L−1 for the 2.9 ACH and 1.7 
ACH, respectively, reflecting airborne concentration numbers commonly found in indoor 
micro-environments.16 It is worth noting here, that the results indicate that S. marcescens in 
its airborne state was stable enough for the purpose of this study. This is attributed to the 
optimized chamber design that facilitates good mixing, has ideal volume, precisely 
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controlled input and output flows and controlled RH. This is in agreement with other studies 
performed by the authors using this particular test bioaerosol.16,47–49
Fig. 5c presents the inactivation results for the case of the 2.9 ACH scenario. The EWNS 
reduced the culturable airborne bacteria concentration, at steady state conditions, by 50% in 
comparison with the control experiments (without EWNS). Furthermore, the EWNS 
completely eradicated (below the limit of detection) the culturable airborne bacteria during 
the decay portion of the experiment, in approximately 30 minutes, which is 50% less time 
compared to the control. Similar results were observed in the 1.7 ACH scenario (Fig. 5d), 
where at steady state the reduction of culturable airborne bacteria was 40%, compared to 
control experiments. In addition, the time for complete removal of culturable bacteria during 
the decay was approximately 30 minutes, and significantly faster compared to the control 
(without EWNS).
It is also evident from the experimental data that the potential of EWNS to remove bacteria 
depends on both the relative ratio of EWNS to bacteria concentrations (rb) and the residence 
time in the chamber, determined by the ventilation rate (ACH). For the 2.9 ACH scenario, 
the ratio rb and the residence time are approximately 7.9 × 106 and 19.5 minutes, 
respectively while for the slower ventilation rate (ACH = 1.7), the rb and residence time are 
3.3 × 106 and 35 minutes, respectively. Although the rb ratio for the 1.7 ACH scenario is 
approximately 60% less compared to the 2.9 ACH scenario, the bacterial removal results are 
similar (50 vs. 40%). This can be attributed to the higher residence time in the case of lower 
rb (35 vs. 19.5 minutes) that allows more time for EWNS–bacteria interactions.
It is worth mentioning that the ozone levels in the chamber were 96 ppb and 132 ppb, for the 
case of the 2.9 ACH and 1.7 ACH respectively. From the literature, such ozone levels are 
not high enough to cause any bacteria inactivation.72 This was also confirmed in our ozone 
control experiments, illustrated in Fig. S6b.‡ Furthermore, the TSA plates inactivation 
control experiments also showed that the bacteria inactivation does not occur on the TSA 
plates of the biosampler, but in the air (Fig. S6a‡).
In summary, the unique properties of the EWNS result in an aerosol that can stay airborne 
for a long time, and has the potential to interact and inactivate airborne bacteria due to its 
high mobility in the air. It is also worth noting here that the presented results are in 
agreement with our previous work that demonstrated the ability of the EWNS to inactivate 
gram-negative (S. marcescens) and gram-positive bacteria (S. aureus) inoculated on the 
surface of stainless steel coupons.73
Bacterial membrane permeability experiments
Although the exact mechanism of inactivation is not the primary focus of this study, some 
preliminary experiments were performed to assess the nature of the bacterial damage 
induced by the EWNS (Fig. 6). Fig. 6a and b illustrate the results from the bacteria 
membrane permeability assay for both the EWNS exposed (9000 # cm−3 for 120 minutes) 
and unexposed bacteria (room air for 120 minutes, control experiments). Bacteria with 
damaged membranes are stained with the membrane-impermeant red fluorescent dye 
(propidium iodide), and show red fluorescence, while those with intact membranes are 
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stained only with the green fluorescent membrane-permeant dye (SYTO 9), and show only 
green fluorescence. Fig. 6c illustrates the quantification of the results by showing the 
percentage of bacteria with damaged membrane. It is apparent that unexposed “healthy” S. 
marcescens bacteria have their outer membrane intact (approximately 20% damage 
compared to the control) while EWNS-exposed bacterium has almost completely damaged 
outer membrane (approximately 98% compared to the control). This was also confirmed and 
shown qualitatively in TEM images in Fig. 6d and e. It is clear from the TEM images that 
the exposed bacteria had their outer membrane completely destroyed as compared to the 
unexposed bacteria that appear to have a complete outer membrane.
It is worth noting that in addition to the primary mode of inactivation which is the 
destruction of the membrane as supported by the membrane permeability data and TEM 
imaging, presented here, there is also the possibility that EWNS could charge the bacteria 
resulting in their removal to the walls. However, in this particular case the walls of the 
environmental chamber were lined with aluminum plates and grounded and any losses to the 
walls were kept minimal.
Among the hypothesized mechanisms for the bacteria inactivation is the ROS mediated 
inactivation due to the presence of ROS species in the EWNS. It is widely recognized that 
ROS species cause oxidative stress, interfere with cell function and viability74 and can cause 
lipid peroxidation of the cell membrane.75 It is reasonable therefore to assume that the ROS 
that are present in the EWNS may lead to inactivation, although other factors may also play 
a role such as the surface charges. A detailed mechanistic study will be planned in the near 
future in order to better understand the biological pathways of bacteria inactivation. 
However, it is clear from the membrane permeability assay data and the TEM images that 
more than 95% of the exposed bacteria lost the integrity of their membrane resulting in the 
release of the cytoplasmic contents. This is similar to what has been observed with other 
nanomaterials that generate ROS and possess biocidal properties, such as TiO276 
nanoparticles.
Toxicological evaluation of inhaled EWNS
Reactive oxygen species can cause oxidative stress in cells and is a well-known mechanism 
of toxicity for metal nanoparticles.24–26 For this reason, an inhalation toxicological study 
was performed using an animal model in order to assess pulmonary toxicity (inflammation 
or injury) under acute exposure conditions.
Fig. 7 shows the biomarkers of lung injury and inflammation, such as LDH, in 
bronchoalveolar lavage (BAL) (Fig. 7a), nasal lavage (NL) (Fig. 7b), albumin (Fig. 7c) and 
neutrophils (Fig. 7d). Fig. 7e and 7f show the changes in tidal volume (Tv) and breathing 
rate (f), respectively, for the EWNS exposed and control animals as a function of time. 
Analyses of variance (using ANOVA) showed no significant differences between the 
controls and EWNS-exposed animals for all the biomarkers.
Collectively the measured biochemical and cellular parameters and breathing patterns 
indicate that a 4 hour exposure to EWNS at levels and lengths of time higher than those that 
were effective in inactivating airborne pathogens did not produce respiratory tract toxicity 
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(the most likely location for an acute response to occur) or changes in breathing patterns. It 
can therefore be concluded that either EWNS have no deleterious effect on the respiratory 
system or that the deposited dose of EWNS in the nose, airways and deep lung was too low 
to elicit a response under acute exposure conditions.
These results seem to contradict reports for the ROS-mediated toxic effects of other 
engineered nanomaterials.24,77,78 Solid nanoparticles have the ability to diffuse into the 
alveolar fluid and being internalized by epithelial cells and macrophages, generating ROS 
that may cause DNA or membrane damage.79 In contrast, when EWNS interact with the 
alveolar or airway fluid, the ROS contents get neutralized by organic molecules before they 
come in contact with epithelial cells, located beneath the lining fluid. Hence, although the 
EWNS contain ROS, they cannot cause any lung injury or inflammation. It is worth 
mentioning that while the acute inhalation study illustrated their biological inert nature, a 
chronic inhalation study is needed in order to address potential toxicological outcomes from 
chronic exposures. Furthermore, in future experiments other forms of human pathogens 
associated with airborne infectious diseases will be investigated such as surrogates of M. 
tuberculosis and strains of influenza virus.
In conclusion, the electrospray-generated EWNS have a set of unique physicochemical 
properties and have the ability to interact with and inactivate airborne bacteria. In addition, 
the EWNS inhalation toxicological study, at similar and higher concentrations required for 
the bacteria removal, showed no significant adverse health effects. Collectively, the results 
showcase that this is a chemical-free, sustainable and environmentally friendly technology 
that has the potential to inactivate airborne pathogens, and reduce the risk of airborne 
infectious diseases in a variety of microenvironments.
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Despite advances in public health, infectious diseases continue to affect millions of 
people, often with serious outcomes. New, innovative, effective, low cost and most 
importantly chemical-free, ‘green’ technologies, possessing fewer drawbacks than the 
existing ones, are urgently needed in the battle against infections. In this work we present 
a new sustainable, chemical free, nanotechnology-based method to inactivate airborne 
bacteria. This technology relies on transforming atmospheric water vapor via 
electrospray into engineered water nano-structures (EWNS). These nano-structures 
possess unique physicochemical and biological properties and have been found to 
interact and inactivate airborne pathogens through destruction of their cell membrane. 
More importantly, they were found to be biologically inert in an acute in vivo inhalation 
study, a clear indication of their potential to be used in the battle against infectious 
diseases.
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(A) The utilized electrospray module with the Peltier cooled electrode, used to condense 
atmospheric humidity. (B) The applied high voltage results in atomizing the condensed 
water and the Rayleigh effect is reducing the size down to the nanoscale level. (C) The 
formed EWNS have a unique structure: an electron rich water shell and contain a number of 
ROS generated during the electrospray process. (D) EWNS due to their nanoscale nature are 
highly mobile and can interact with airborne pathogens.
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The AFM measured size distribution and stability of the EWNS. (A) A 3D AFM image of 
the EWNS as spread on a mica surface. (B) The AFM measured size distribution of the 
EWNS as measured by the AFM. The average diameter was found to be 25.17 nm and 
follows a log normal distribution with geometric standard deviation 1.41. (C–H) Progressive 
scans of the EWNS on a mica surface at 10 minutes intervals (up to 55 minutes). There is no 
apparent difference in the deposited EWNS size over time. The scan area is 5 µm × 5 µm. (I) 
AFM scan of a freshly cleaved mica surface at t = 0 (before spraying the EWNS). (J) AFM 
scan of a control mica surface (freshly cleaved mica surface) left in room air during the 
experiment (60 minutes).
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EWNS number concentration as a function of the time in a closed chamber after the 
generation has stopped. After one hour 50% of the particles remain while they are still 
present after 4 hours.
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The ESR spectrum, demonstrating the presence of O2− and OH• radicals.
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Airborne bacteria inactivation experimental results. (A) The size distribution of the bio-
aerosol and EWNS aerosol as measured by the N6 six-stage viable impactor and the CPC 
respectively, for the 2.9 ACH ventilation scenario. (B) The size distribution of the 
bioaerosol and EWNS aerosol as measured by the N6 six-stage viable impactor and the 
SMPS respectively for the 1.7 ACH ventilation scenario. (C) The airborne bacteria 
inactivation results both for steady state and decay scenarios for the 2.9 ACH. (D) Similar 
results for the 1.7 ACH scenario.
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The mechanistic analysis results. (A) The control (unexposed) bacteria and (B) the exposed 
to the EWNS for 120 minutes. (C) The quantification of the obtained images indicating the 
percentage of bacteria with damaged membrane. TEM images from (D) control (unexposed) 
bacteria and (E) TEM image of EWNS exposed bacteria for 90 minutes.
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BAL and NL biomarkers of injury and inflammation post-exposure to EWNS. (A) BAL 
LDH, (B) NL LDH, (C) BAL albumin and (D) BAL neutrophil numbers. For all the 
endpoints, the ANOVA analysis showed no statistical difference. (E) The normalized tidal 
volume and (F) normalized breathing frequency showed during and after the exposure no 
difference between exposed and controls. The standard deviation was used as error.
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